Best Radiotherapy for breast cancer Doctors Worldwide — TOP 48

Dr. Seifert leads the Breast Cancer Center at Solingen Clinic, specializing in breast-sparing surgeries and aesthetic reconstruction.

• 26 years of experience of experience in gynecology and breast health
• Expert in breast-sparing techniques for better aesthetic outcomes
• Provides comprehensive care from diagnosis to postoperative support
• Combines medical expertise with personalized psychological support

Dr. Ari Raphael leads genomic oncology initiatives at Sourasky Medical Center, specializing in breast cancer radiotherapy with a focus on precision medicine.

• Senior Lecturer at Tel Aviv University's Faculty of Medicine
• PI for clinical trials using genomic predictors of treatment response
• Molecular Tumor Board moderator for the Israeli Lung Cancer Society
• Honored with multiple teaching awards from Tel-Aviv University
• European Society of Medical Oncology (ESMO) member

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Associate Professor Ofer Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in breast cancer radiotherapy.

• Over 41 years of experience of experience in oncology
• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Sarcoma group faculty
• Published extensively on breast cancer treatments
• Head of Oncology Outpatient Clinic at Sourasky

Specialist in Oncological Gynecology and Radiotherapy with expertise in breast cancer treatment at Sourasky Medical Center (Ichilov).

• Focuses on personalized radiotherapy plans for breast cancer patients
• Combines gynecological oncology with radiotherapy for comprehensive care
• Works at one of Israel's leading medical centers

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Doctor Sefik Igdem specializes in Radiation Oncology, with advanced expertise in Truebeam Stx and Halcyon technologies.

• Over 30 years of experience of experience in radiation oncology
• Specializes in head and neck cancers and prostate cancer
• Associate Professor and later Professor at Demiroğlu Bilim University
• Uses conformal treatments for precise radiation therapy

Specializes in breast cancer surgery and radiotherapy, with extensive experience in breast-conserving techniques and neoadjuvant chemotherapy at Atlas University Hospital.

• Over 29 years of experience of experience in general surgery with a focus on breast cancer
• Certified in advanced breast cancer treatments and reconstructions
• Published multiple research articles on breast cancer outcomes and treatments
• Associate Professor at Istanbul Gaziosmanpaşa Taksim Education and Research Hospital

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Head of Radiation Oncology at German Oncology Center – specializes in precise, targeted breast cancer radiotherapy.

• 13 years of experience in radiation oncology with a focus on breast cancer
• Trained at prestigious institutions in Germany and Greece
• Combines clinical expertise with advanced academic qualifications
• Leads a specialized department in Cyprus

Specialized in breast cancer radiotherapy at Hacettepe University Cancer Institute – one of Turkey's leading oncology centers.

• Fellowship-trained at The University of Texas MD Anderson Cancer Center
• Handles complex cases including breast, ovarian, and lung cancers
• Works at Hisar Hospital Intercontinental's advanced radiotherapy unit

Specializes in advanced radiotherapy techniques for breast cancer treatment at Anadolu Medical Center – including MR Linac and CyberKnife for precise targeting.

• Completed specialist training in Radiation Oncology at Kocaeli University
• Uses Varian TrueBeam нельзя -- требуется больше информации из данных для заполнения полей. К сожалению, предоставленных данных недостаточно для полного заполнения всех требуемых полей в соответствии с инструкцией, в частности пунктов good_fit_for и what_sets_doctor_apart, которые должны быть основаны на конкретных фактах и специализации доктора.

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads breast cancer treatment teams.

• 26 years of experience experience in oncology
• Specializes in internal medicine and oncology
• Conducted numerous clinical trials
• Trained at Tel Aviv Medical Center

The doctor is a highly qualified medical oncologist specializing in breast cancer across all clinical stages, including curative and palliative care. With a medical degree from the Pontificia Universidad Católica del Ecuador and a five-year residency at Hospital de la Santa Creu i Sant Pau, the doctor holds a Master's Degree in Medical Oncology from the Spanish Society of Medical Oncology (SEOM).

Currently practicing at the International Breast Cancer Center (IBCC) and IOB Institute of Oncology Barcelona, the doctor has extensive experience in Phase I clinical trials and research. Clinical expertise extends to neuroendocrine tumors, gynecological cancers, and immunotherapy for non-small cell lung cancer. The doctor is an active member of SEOM and ESMO.

Specializes in comprehensive breast cancer treatment, including radiation therapy, at the certified interdisciplinary cancer centre BKZ Solingen.

• 14 years of experience of experience in haematology and oncology
• Qualified specialist in genetics and molecular diagnostics
• Member of German and American oncology societies
• Involved in molecular biology research for innovative treatments

Dr. Séverine Iborra leads the Gynecology Department at Städtisches Klinikum Solingen, specializing in breast cancer care at Bergisches Breast Center.

• Certified in gynecological oncology with additional qualifications in oncological diagnostics
• Expert in minimally invasive treatments using laparoscopy and Da Vinci robotic system
• Active member of leading German medical societies in gynecology
• Published numerous papers and presented at major gynecological conferences